Effect of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 1, 1998, Pages 21-24

  Klein, Gordon L ^a,b   Wolf, Steven E ^a,b   Langman, Craig B ^c   Rosen, Clifford J ^d   Mohan, Subburaman ^e   Keenan, Bruce S ^a   Matin, Sina ^a,b   Steffen, Christopher ^d   Nicolai, Marc ^b   Sailer, Dawn E ^c   Herndon, David N ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b Shriners Burns Institute   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d ST JOSEPH HOSPITAL   (United States)

^e LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; HUMAN GROWTH HORMONE; SOMATOMEDIN; BIOLOGICAL MARKER; OSTEOCALCIN; RECOMBINANT PROTEIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C;

ARTICLE; BONE ATROPHY; BONE GROWTH; BONE METABOLISM; BURN; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GROWTH ACCELERATION; HUMAN; MALE; MORPHOMETRICS; OSSIFICATION; PRIORITY JOURNAL; WOUND HEALING; BLOOD; BONE DENSITY; BONE DEVELOPMENT; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; METABOLISM; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SPINE;

BIOLOGICAL MARKERS; BONE DENSITY; BONE DEVELOPMENT; BURNS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; OSTEOCALCIN; RECOMBINANT PROTEINS; SPINE; WOUND HEALING;

EID: 15444351059     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.1.21     Document Type: Article

References (24)

1. Klein GL, Herndon DN, Rutan TC, et al. 1993 Bone disease in burn patients. J Bone Miner Res. 8:337-345.
2. Klein GL, Herndon DN, Goodman WG, et al. 1995 Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 17:455-460.
3. Klein GL, Herndon DN, Langman CB, et al. 1995 Long-term reduction in bone mass following severe burn injury in children. J Pediatr. 126:252-256.
4. Rutan RL, Herndon DN. 1990 Growth delay in postburn patients. Arch Surg. 125:392-395.
5. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. 1990 Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg. 212:424-431.
6. Gilpin DA, Barrow RE, Rutan RL, Broemeling L, Herndon DN. 1994 Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg. 220:19-24.
7. Fleming RYD, Rutan RL, Jahoor F, Barrow RE, Wolfe RR, Herndon DN. 1992 Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma. 32:698-703.
8. Zamboni G, Antoniazzi F, Radetti G, Musumesi C, Tato L. 1991 Effects of two different regimens of recombinant growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr. 119:483-485.
9. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, DiNero G. 1993 Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr. 122:37-45.
10. Delmas PD, Chatelain P, Malaval L, Bonne G. 1986 Serum bone Gla-protein in growth hormone-deficient children. J Bone Miner Res. 1:333-338.
11. Sanchez CF, Goodman WG, Brandli D, et al. 1995 Skeletal response to recombinant human growth hormone (rHGH) in children treated with long-term corticosteroids. J Bone Miner Res. 10:2-6.
12. Herndon DN, Rutan RL, Alison Jr WG, Cox Jr CC. 1993 Management of burn injuries. In: Eichelberger MR, ed. Pediatric trauma: prevention, acute care, and rehabilitation. St. Louis: Mosby-Yearbook; 568-540.
13. Nichols Institute Diagnostics. 1997 Directional insert. IGF-1 by IRMA. San Juan Capistrano, CA: Nichols Institute; 1-14.
14. Nichols Institute Diagnostics. 1995 Directional insert for the quantitative determination of IGFBP-3 in human serum. San Juan Capistrano, CA: Nichols Institute; 1-26.
15. Scharla SH, Strong DD, Rosen CJ, et al. 1993 1,25-dihydroxyvitamin D increases expression of BP-4 in human OB like cells in vitro and elevates IGFBP-4 serum levels in vivo. J Clin Endocrinol Metab. 77:1190-1197.
16. Honda Y, Lansdale EC, Strong DD, Baylink DJ, Mohan S. 1996 Recombinant synthesis of insulin-like growth factor binding protein-4 (IGFBP-4). Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocrinol Metab. 81:1389-1396.
17. Mohan S, Libanati C, Dony C, Lang K, Srinavasan N, Baylink DJ. 1995 Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metrab. 80:2638-2645.
18. Reed A, Haugen M, Pachman LM, Langman CB. 1990 Abnormalities of serum osteocalein in children with chronic rheumatic diseases. J Pediatr. 116:574-580.
19. McCarthy TL, Centrella M, Canalis E. 1989 Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology. 124:301-309.
20. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S. 1994 Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res. 9:915-921.
21. Ono T, Kanzaki S, Seino Y, Baylink DJ, Mohan S. 1996 Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF binding proteins-3 and-5, and bone alkaline phosphatase isoenzyme. J Clin Endocrinol Metab. 81:2111-2116.
22. Wraight CJ, Murashita MM, Russo VC, Werther GA. A keratinocyte cell line synthesizes a predominant IGFBP-4 that modulates IGF-1 action. J Invest Dermatol. 103:627-631.
23. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD. 1990 Inhibitory IGFBP: cloning complete sequence and physiological regulation. Mol Enciocrinol. 4:1806-1814.
24. Klein GL, Nicolai M, Langman CB, Cuneo BF, Sailer DE, Herndon DN. 1997 Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J Pediatr. 131:246-251.